Tae‐Young Oh

488 total citations
18 papers, 423 citations indexed

About

Tae‐Young Oh is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Tae‐Young Oh has authored 18 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Pharmacology. Recurrent topics in Tae‐Young Oh's work include Natural product bioactivities and synthesis (3 papers), Allergic Rhinitis and Sensitization (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). Tae‐Young Oh is often cited by papers focused on Natural product bioactivities and synthesis (3 papers), Allergic Rhinitis and Sensitization (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). Tae‐Young Oh collaborates with scholars based in South Korea and Poland. Tae‐Young Oh's co-authors include Ki‐Baik Hahm, Jeong‐Sang Lee, Soo‐Jin Park, Chang‐Duk Jun, Suck‐Chei Choi, Ryowon Choue, Young‐Joon Surh, Eun‐Ju Choi, Hyun‐Mee Oh and Chang‐Soo Choi and has published in prestigious journals such as Gastroenterology, Pharmaceutical Research and Journal of Cellular Biochemistry.

In The Last Decade

Tae‐Young Oh

17 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tae‐Young Oh South Korea 10 156 108 75 66 65 18 423
Takamasa Ohno Japan 13 179 1.1× 47 0.4× 69 0.9× 60 0.9× 81 1.2× 25 466
Mi Ae Kang South Korea 12 331 2.1× 57 0.5× 71 0.9× 67 1.0× 78 1.2× 22 810
Fangshi Zhu China 10 198 1.3× 47 0.4× 54 0.7× 42 0.6× 95 1.5× 25 429
Manal F. Ismail Egypt 15 236 1.5× 62 0.6× 44 0.6× 52 0.8× 92 1.4× 28 577
Qiqi Xin China 14 235 1.5× 67 0.6× 81 1.1× 86 1.3× 48 0.7× 36 609
Ying‐Kai Hong China 12 172 1.1× 58 0.5× 41 0.5× 75 1.1× 94 1.4× 20 510
Zhu-Jun Mao China 15 251 1.6× 63 0.6× 46 0.6× 56 0.8× 43 0.7× 39 554
Masahiro Fuchigami Japan 12 209 1.3× 67 0.6× 71 0.9× 59 0.9× 52 0.8× 16 490
Dake Cai China 14 274 1.8× 62 0.6× 61 0.8× 123 1.9× 47 0.7× 35 573

Countries citing papers authored by Tae‐Young Oh

Since Specialization
Citations

This map shows the geographic impact of Tae‐Young Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tae‐Young Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tae‐Young Oh more than expected).

Fields of papers citing papers by Tae‐Young Oh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tae‐Young Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tae‐Young Oh. The network helps show where Tae‐Young Oh may publish in the future.

Co-authorship network of co-authors of Tae‐Young Oh

This figure shows the co-authorship network connecting the top 25 collaborators of Tae‐Young Oh. A scholar is included among the top collaborators of Tae‐Young Oh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tae‐Young Oh. Tae‐Young Oh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Oh, Tae‐Young, et al.. (2021). Bioequivalence for a Fixed‐Dose Combination Formulation of Bazedoxifene and Cholecalciferol Compared With the Corresponding Single Entities Given Together. Clinical Pharmacology in Drug Development. 10(8). 850–858. 1 indexed citations
3.
Oh, Tae‐Young, et al.. (2020). Pharmacokinetic comparison of two bazedoxifene acetate 20 mg tablet formulations in healthy Korean male volunteers. Translational and Clinical Pharmacology. 28(2). 102–102. 3 indexed citations
4.
Oh, Tae‐Young, et al.. (2020). A randomized, open-label, crossover study to compare the safety and pharmacokinetics of two tablet formulations of tenofovir (tenofovir disoproxil and tenofovir disoproxil fumarate) in healthy subjects. International Journal of Clinical Pharmacology and Therapeutics. 58(12). 749–756. 1 indexed citations
5.
Choi, Eun‐Ju, Hyun‐Mee Oh, Chang‐Soo Choi, et al.. (2009). Eupatilin exhibits a novel anti-tumor activity through the induction of cell cycle arrest and differentiation of gastric carcinoma AGS cells. Differentiation. 77(4). 412–423. 35 indexed citations
6.
Kim, Young‐Dae, Suck‐Chei Choi, Tae‐Young Oh, Jang‐Soo Chun, & Chang‐Duk Jun. (2009). Eupatilin inhibits T‐cell activation by modulation of intracellular calcium flux and NF‐κB and NF‐AT activity. Journal of Cellular Biochemistry. 108(1). 225–236. 13 indexed citations
7.
Kim, Hyun Soo, Joydeb Kumar Kundu, Jeong‐Sang Lee, et al.. (2008). Chemopreventive Effects of the Standardized Extract (DA-9601) ofArtemisia asiaticaon Azoxymethane-Initiated and Dextran Sulfate Sodium-Promoted Mouse Colon Carcinogenesis. Nutrition and Cancer. 60(sup1). 90–97. 21 indexed citations
8.
Choi, Eun‐Ju, Hyun‐Mee Oh, Bo-Ra Na, et al.. (2008). Eupatilin Protects Gastric Epithelial Cells from Oxidative Damage and Down-Regulates Genes Responsible for the Cellular Oxidative Stress. Pharmaceutical Research. 25(6). 1355–1364. 62 indexed citations
9.
10.
Lee, Jeong‐Sang, et al.. (2006). Chemopreventive effects of curcumin on azoxymethane-initiated and dextran sulfate sodium-promoted mouse colon carcinogenesis. 66. 537–538. 1 indexed citations
11.
Lee, Soyoung, Won‐Hwan Park, Cheorl‐Ho Kim, et al.. (2006). DA-9601 Decreases Immediate-Type Allergic Reaction and Tumor Necrosis Factor-.ALPHA. Production. JOURNAL OF HEALTH SCIENCE. 52(4). 383–389. 2 indexed citations
12.
Oh, Tae‐Young, Young‐Bae Kim, Marie Yeo, et al.. (2005). Novel antioxidant ameliorates the fibrosis and inflammation of cerulein-induced chronic pancreatitis in a mouse model. Pancreatology. 5(2-3). 165–176. 57 indexed citations
13.
Lee, Jeong‐Sang, et al.. (2005). Protective effects of green tea polyphenol extracts against ethanol-induced gastric mucosal damages in rats: Stress-responsive transcription factors and MAP kinases as potential targets. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 579(1-2). 214–224. 56 indexed citations
14.
Park, Soo‐Jin, et al.. (2004). Preventive Effect of the Flavonoid, Wogonin, Against Ethanol-Induced Gastric Mucosal Damage in Rats. Digestive Diseases and Sciences. 49(3). 384–394. 70 indexed citations
15.
Oh, Tae‐Young, et al.. (2001). Oxidative damages are critical in pathogenesis of reflux esophagitis; Implication of antioxidants in its treatment. Gastroenterology. 120(5). A112–A112. 8 indexed citations
16.
Oh, Tae‐Young, et al.. (2001). Efficacy of use of colonoscopy in dextran sulfate sodium induced ulcerative colitis in rats: the evaluation of the effects of antioxidant by colonoscopy. International Journal of Colorectal Disease. 16(3). 174–181. 43 indexed citations
17.
Oh, Tae‐Young, et al.. (1999). Accelerated Wound Healing by ]Recombinant Human Basic Fibroblast Growth Factor in Healing-impaired Animal Models. Biomolecules & Therapeutics. 7(1). 7–13. 1 indexed citations
18.
Oh, Tae‐Young, et al.. (1997). Beneficial Effect of DA-9601, an Extract of Artemisiae Herba, on Animals Models of Inflammatory Bowel Disease. Biomolecules & Therapeutics. 5(2). 165–173. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takamasa Ohno Breakdown of academic impact, for papers by Mi Ae Kang Breakdown of academic impact, for papers by Fangshi Zhu Breakdown of academic impact, for papers by Manal F. Ismail Breakdown of academic impact, for papers by Qiqi Xin Breakdown of academic impact, for papers by Ying‐Kai Hong Breakdown of academic impact, for papers by Zhu-Jun Mao Breakdown of academic impact, for papers by Masahiro Fuchigami Breakdown of academic impact, for papers by Dake Cai
Rankless by CCL
2026